Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
Bjarnason
Nina H
NH
Center for Clinical and Basic Research, Ballerup Byvej 222, DK-2750 Ballerup, Denmark. nina.bjarnason@adslhome.dk
D000818:Animals; D050197:Atherosclerosis / Q000503:physiopathology; D001842:Bone and Bones / Q000502:physiology; D002319:Cardiovascular System / Q000503:physiopathology; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000502:physiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009652:Norpregnenes / Q000009:adverse effects / Q000627:therapeutic use*; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control; D017698:Postmenopause; D020849:Raloxifene Hydrochloride / Q000009:adverse effects / Q000627:therapeutic use*; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*
D004967:Estrogens; D009652:Norpregnenes; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride; C027385:tibolone